Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The intricate interaction of variables influencing the demand, supply, and total growth of the pharmaceutical industry is reflected in the market dynamics of gastrointestinal medications in the Europe, Middle East, and Africa (EMEA) region.
Market Size and Growth: Due to the rising incidence of gastrointestinal illnesses in the area, the market for gastrointestinal medications in EMEA has grown significantly in recent years. The market is growing, and there is a discernible increase in the need for efficient treatment alternatives.
Disease Prevalence and Demographics: In the EMEA area, there is an increase in the prevalence of gastrointestinal illnesses, such as irritable bowel syndrome, gastric reflux disease, and inflammatory bowel disease. This increase is linked to variables including food preferences, aging populations, and changing lifestyles, which increase the number of patients in need of pharmacological treatments.
The gastrointestinal medicines industry is subject to major changes influenced by the regulatory landscape. Tight laws and lengthy clearance procedures affect new medication launches, reshaping the industry and pharmaceutical firms' approaches to market share in the area.
Competitive Landscape: Well-established pharmaceutical businesses are in fierce competition with one another for market share, which defines the market. There is a fierce rivalry as businesses concentrate on R&D to launch novel medications that meet unmet medical requirements.
Market Trends and Innovations: The EMEA gastrointestinal medicines market is being shaped by ongoing developments in drug development, such as the introduction of biologics and targeted treatments. Improvements in patient compliance and treatment results are a result of innovations in medication delivery techniques and formulations.
Healthcare Infrastructure: A key factor in affecting market dynamics is the caliber and accessibility of the healthcare infrastructure. Gastrointestinal medicine adoption rates are impacted by variations in healthcare systems throughout EMEA nations; variances in pricing and accessibility influence market expansion.
Economic Factors: Market dynamics are influenced by a number of economic factors, such as healthcare expenditure, reimbursement practices, and general economic stability. The accessibility of gastrointestinal medications is determined by factors such as affordability and insurance coverage, which influence market penetration.
Emerging Markets: The pharmaceutical industry, which includes gastrointestinal medications, is growing as the economies of the Middle East and Africa continue to flourish. Market participants can take advantage of emerging markets to capitalize on expanding populations and unmet medical requirements.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|
Europe Gastrointestinal Drugs Market Highlights:
Europe, Middle East and Africa Gastrointestinal Drugs Market Scenario:
Gastrointestinal (GI) drug market is projected to reach USD 6,000.27 Million by 2030 at 6.8% CAGR during the forecast period 2022-2030. Gastroesophageal reflux is the most common disease and is responsible for generating a good market. The major driving factor for this market are increasing prevalence of many gastrointestinal disease. In addition to this, technological advances, infrastructure development increasing investment in research activity and increasing awareness about the availability of treatment are responsible for providing fuel for the growth of the market. While incorrect self-diagnosis and availability of many misbranded drug are the major restraining factor for the growth of market. Study Objectives Europe, Middle East and Africa Gastrointestinal Drugs Market Research Report
- Market Analysis of Europe, Middle East and Africa Gastrointestinal Drugs Market, with region assessment and competitive analysis.
- Detail market identification with its drivers and restrain of the market.
- To provide thorough understanding of various segment and sub segments of the market.
- Analysis of market on the basis of different factors like price analysis, supply chain analysis, porters five force analysis etc.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to their main geographies and their countries
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Europe, Middle East and Africa Gastrointestinal Drugs Market.
- Information about the key companies that may influence this market in this region.
Figure 1- Europe, Middle East and Africa Gastrointestinal Drugs Market, by Disease type 
Key Players for Europe, Middle East and Africa Gastrointestinal Drugs market AstraZeneca Plc.(UK), Johnson & Johnson (US), Takeda Pharmaceutical Company Limited (Japan), Eisai Co., Ltd. (Japan), Valeant Pharmaceuticals Inc. (US), Sanofi Ltd. (France), Valeant (US), Abbott Laboratories(US), Allergan Plc (US), Bayer AG (Germany), Janssen Biotech Inc. (US), AbbVie Inc. (US), Janssen Biotech (US), GlaxoSmithKline Plc. (UK), Boehringer Ingelheim GmbH (Germany). Segmentation Europe, Middle East and Africa gastrointestinal drugs market has been segmented on the basis of Drug Category they are segmented into Acid Neutralizers, Laxatives and Antidiarrheal, antiemetic, Anti-inflammatory drugs and other. Acid Neutralizers are further sub segmented into Antacids, H2 antagonists, Proton pump inhibitors and others. By Route of Administration they are segmented into Oral, Parenteral and rectal. By disease type they are segmented into Gastroesophageal Reflux Disease, Inflammatory Bowel Disease and Other. By End User Hospital Pharmacies, Retail Pharmacies and Other
Research Methodology
Regional Analysis Europe is the second major contributor in the GI drug market globally. Total Europe and Middle East and Africa GI drug market in 2016 was approximately USD$ 15 million. Germany and France are the major contributor of the market this is due to a huge number of patient suffering from different GI problems. About 9.2% of total population in France is suffering from acute or chronic GI problems. This is the major factor responsible for the growth of market. Due to saturation of market in this region the market is growing at a steady CAGR of 4.5 % during 2017-2023.
The report for Europe, Middle East and Africa Gastrointestinal Drugs Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
 Intended Audience
- Manufacturing industries.
- Pharmaceutical industry.
- Biotechnology Companies
- Research and Development (R&D) CompaniesÂ
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
